Joana Dias has completed her Masters in Veterinary Medicine in 2012 at the Faculty of Veterinary Medicine from the University Of Lisbon, Portugal. In 2019, she completed her PhD in Veterinary Science, also at the University Of Lisbon, where she worked in the development of novel antibody-based therapies for non-Hodgkin lymphoma, while contributing for the validation of the canine lymphoma model for translational immune-oncology research. Currently she is completing her degree in Medicine at Nova Medical School. Joana is a veterinarian with clinical background and biomedical researcher with 9 years of experience and is currently a contracted Researcher at the Microbiology and Immunology Lab from the Universidade de Lisboa, Faculdade de Medicina Veterinária. Joana aims to become a physician and medical researcher that works side by side with patients while focus in developing novel therapeutics that can provide greater benefit to patients compared with current drugs. By leveraging her expertise in clinical translational research, comparative oncology, drug development, antibody engineering, animal experimentation and medical clinical training, she aims to usher-in a new generation of immunotherapies and antibody-based nanomedicines for cancer.